Javascript must be enabled to continue!
Prevalence and Variation of BMI in Patients Undergoing Abdominoplasty: A Retrospective Study in A Private Service
View through CrossRef
1.1. Background Body Mass Index (BMI) is a statistical tool used to estimate body fat based on a person’s weight and height. This index applies to men and women of all ages, categorizing them as underweight, normal weight, overweight, or obese. These classifications are widely adopted by the World Health Organization (WHO) for white, Hispanic, and black populations. Abdominoplasty is a surgical procedure designed to remove excess skin and fat from the abdominal region and strengthen the abdominal wall muscles. BMI plays a key role in this surgery, as it helps assess whether the patient is within an ideal weight range to optimize results and reduce procedure-related risks. 1.2. Objectives To investigate the prevalence and variation of Body Mass Index (BMI) in patients undergoing abdominoplasty in a private practice, analyzing its relationship with surgical outcomes and associated risks. 1.3. Methods A review of medical records was conducted for 15 patients who underwent abdominoplasty between October and December 2024 at the Giovanni Augustus Morais e Silva Plastic Surgery office. The analysis included weight and height measurements. 1.4. Results During the analyzed period, 15 female patients underwent abdominoplasty. Their pre-surgical BMI ranged from 21.02 to 33.20. Based on the BMI obesity classification table, the patients were distributed as follows: 3 patients (20%) had a normal weight, 8 patients (53.3%) were overweight, and 4 patients (26.6%) were classified as having grade I obesity. The mean BMI was 26.12, categorizing the group as overweight. No patients were recorded as underweight or in the categories of grade II or III obesity
Annals of Clinical and Medical Case Reports
Title: Prevalence and Variation of BMI in Patients Undergoing Abdominoplasty: A Retrospective Study in A Private Service
Description:
1.
1.
Background Body Mass Index (BMI) is a statistical tool used to estimate body fat based on a person’s weight and height.
This index applies to men and women of all ages, categorizing them as underweight, normal weight, overweight, or obese.
These classifications are widely adopted by the World Health Organization (WHO) for white, Hispanic, and black populations.
Abdominoplasty is a surgical procedure designed to remove excess skin and fat from the abdominal region and strengthen the abdominal wall muscles.
BMI plays a key role in this surgery, as it helps assess whether the patient is within an ideal weight range to optimize results and reduce procedure-related risks.
1.
2.
Objectives To investigate the prevalence and variation of Body Mass Index (BMI) in patients undergoing abdominoplasty in a private practice, analyzing its relationship with surgical outcomes and associated risks.
1.
3.
Methods A review of medical records was conducted for 15 patients who underwent abdominoplasty between October and December 2024 at the Giovanni Augustus Morais e Silva Plastic Surgery office.
The analysis included weight and height measurements.
1.
4.
Results During the analyzed period, 15 female patients underwent abdominoplasty.
Their pre-surgical BMI ranged from 21.
02 to 33.
20.
Based on the BMI obesity classification table, the patients were distributed as follows: 3 patients (20%) had a normal weight, 8 patients (53.
3%) were overweight, and 4 patients (26.
6%) were classified as having grade I obesity.
The mean BMI was 26.
12, categorizing the group as overweight.
No patients were recorded as underweight or in the categories of grade II or III obesity.
Related Results
Postoperative Complications of Panniculectomy and Abdominoplasty
Postoperative Complications of Panniculectomy and Abdominoplasty
Background
Recent studies of panniculectomy outcomes have reported variable complication rates ranging from 8.65% to 56%. Meanwhile, reported abdominoplasty complicatio...
Post-Bariatric Surgery Abdominoplasty Ameliorates Psychological Well-Being in Formerly Obese Patients: A Cross-Sectional Recall Study
Post-Bariatric Surgery Abdominoplasty Ameliorates Psychological Well-Being in Formerly Obese Patients: A Cross-Sectional Recall Study
Background: Bariatric surgery is an effective treatment for obesity, leading to significant weight loss and improvements in metabolic health. However, massive weight loss often res...
Patient Weight and Chemoprophylaxis in Abdominoplasty: Does It Result in More Bleeding Events?
Patient Weight and Chemoprophylaxis in Abdominoplasty: Does It Result in More Bleeding Events?
Abstract
Background
Bariatric surgery has gained popularity in recent decades as an effective treatment for obesity. Abdominoplasty is one of the mo...
Ubap2l-Bmi-1-Rnf2 Define a Novel Polycomb Complex Essential For Self-Renewal Of Hematopoietic Stem Cells
Ubap2l-Bmi-1-Rnf2 Define a Novel Polycomb Complex Essential For Self-Renewal Of Hematopoietic Stem Cells
Abstract
The polycomb group protein Bmi-1 is a well known determinant of hematopoietic stem cell function. Bmi-1-/- mice display severe hematopoietic defects, includ...
Abdominoplasty in the Obese Patient: Risk versus Reward
Abdominoplasty in the Obese Patient: Risk versus Reward
Background:
The incidence of obesity is on the rise worldwide. Many surgeons elect not to perform abdominoplasty on patients with a high body mass index, fearing an inc...
SP7.1.2 DVT and Abdominoplasty: A Holistic 8-point protocol-based approach to prevent DVT
SP7.1.2 DVT and Abdominoplasty: A Holistic 8-point protocol-based approach to prevent DVT
Abstract
Aim
Plastic surgery as a speciality is afflicted with one of the highest incidence rates of thromboembolic events, with...
1058 DVT And Abdominoplasty: A Holistic 8-Point Protocol-Based Approach to Prevent DVT
1058 DVT And Abdominoplasty: A Holistic 8-Point Protocol-Based Approach to Prevent DVT
Abstract
Aim
Plastic surgery as a speciality is afflicted with one of the highest incidence rates of thromboembolic events, with...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

